TD Cowen analyst Joshua Buchalter raised the firm’s price target on Arteris (AIP) to $16.50 from $15 and keeps a Buy rating on the shares. The firm said its Q3 results and FlexGen momentum presented firm fundamentals traction that met expectations.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIP:
- Arteris, Inc. Reports Strong Q3 Growth Amid Losses
- Arteris: Strong Market Position and Growth Potential Highlighted by Strategic Wins and AI Focus
- Arteris reports Q3 EPS (9c), consensus (9c)
- Arteris sees Q4 revenue $18.4M-$18.8M, consensus $18.12M
- Arteris narrows FY25 revenue view to $68.8M-$69.2M from $66M-$70M